BDTX - Black Diamond Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

BDTX is currently covered by 3 analysts with an average price target of $14.43. This is a potential upside of $9.05 (168.22%) from yesterday's end of day stock price of $5.38.

Black Diamond Therapeutics's activity chart (see below) currently has 8 price targets and 18 ratings on display. The stock rating distribution of BDTX is 20% HOLD and 80% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26.39% with an average time for these price targets to be met of 71.25 days.

Highest price target for BDTX is $16, Lowest price target is $10, average price target is $14.43.

Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 08-Apr-2024. First documented stock forecast 24-Feb-2020.

Best performing analysts who are covering BDTX - Black Diamond Therapeutics:

Robert Driscoll Bradley Canino Eric Joseph Robert Burns

Currently out of the existing stock ratings of BDTX, 2 are a HOLD (20%), 8 are a BUY (80%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

16

$10.65 (199.07%)

10

10 days ago

2/9 (22.22%)

$10.65 (199.07%)

94

Buy

12

$6.65 (124.30%)

11

1 months ago

0/4 (0%)

$7.3 (155.32%)

Buy

10

$4.65 (86.92%)

2

9 months 19 days ago

2/4 (50%)

$4.95 (98.02%)

117

Buy

24

$22.42 (1418.99%)

44

2 years 10 months 29 days ago

1/3 (33.33%)

$13.28 (63.42%)

74

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BDTX (Black Diamond Therapeutics) average time for price targets to be met?

On average it took 71.25 days on average for the stock forecasts to be realized with a an average price target met ratio 26.39

Which analyst has the current highest performing score on BDTX (Black Diamond Therapeutics) with a proven track record?

ROBERT DRISCOLL

Which analyst has the current lower performing score on BDTX (Black Diamond Therapeutics) with a proven track record?

ROBERT BURNS

Which analyst has the most public recommendations on BDTX (Black Diamond Therapeutics)?

Robert Driscoll works at WEDBUSH and has 11 price targets and 8 ratings on BDTX

Which analyst is the currently most bullish on BDTX (Black Diamond Therapeutics)?

Eric Joseph with highest potential upside - $22.42

Which analyst is the currently most reserved on BDTX (Black Diamond Therapeutics)?

Bradley Canino with lowest potential downside - $4.65

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?